These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Decreased interleukin-20 level in patients with systemic sclerosis: are they related with angiogenesis? Aydoğdu E; Pamuk ÖN; Dönmez S; Pamuk GE Clin Rheumatol; 2013 Nov; 32(11):1599-603. PubMed ID: 23812620 [TBL] [Abstract][Full Text] [Related]
27. The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis. Solanilla A; Villeneuve J; Auguste P; Hugues M; Alioum A; Lepreux S; Ducroix JP; Duhaut P; Conri C; Viallard JF; Nurden AT; Constans J; Ripoche J Rheumatology (Oxford); 2009 Sep; 48(9):1036-44. PubMed ID: 19549789 [TBL] [Abstract][Full Text] [Related]
28. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Rana S; Karumanchi SA; Levine RJ; Venkatesha S; Rauh-Hain JA; Tamez H; Thadhani R Hypertension; 2007 Jul; 50(1):137-42. PubMed ID: 17515455 [TBL] [Abstract][Full Text] [Related]
29. Serum levels of vascular dysfunction markers reflect disease severity and stage in systemic sclerosis patients. Cossu M; Andracco R; Santaniello A; Marchini M; Severino A; Caronni M; Radstake T; Beretta L Rheumatology (Oxford); 2016 Jun; 55(6):1112-6. PubMed ID: 26989111 [TBL] [Abstract][Full Text] [Related]
30. The role of asymmetric dimethylarginine in endothelial dysfunction and abnormal nitric oxide metabolism in systemic sclerosis: results from a pilot study. Pagkopoulou E; Soulaidopoulos S; Katsiki N; Malliari A; Loutradis C; Karagiannis A; Doumas M; Garyfallos A; Kitas G; Dimitroulas T Clin Rheumatol; 2023 Apr; 42(4):1077-1085. PubMed ID: 36534350 [TBL] [Abstract][Full Text] [Related]
31. Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis. Romano E; Manetti M; Rosa I; Fioretto BS; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S Ann Rheum Dis; 2018 Nov; 77(11):1665-1674. PubMed ID: 30021803 [TBL] [Abstract][Full Text] [Related]
32. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin]. Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902 [TBL] [Abstract][Full Text] [Related]
33. Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis. Manetti M; Pratesi S; Romano E; Bellando-Randone S; Rosa I; Guiducci S; Fioretto BS; Ibba-Manneschi L; Maggi E; Matucci-Cerinic M PLoS One; 2017; 12(8):e0183102. PubMed ID: 28797111 [TBL] [Abstract][Full Text] [Related]
34. Soluble fms-like tyrosine kinase 1 and soluble endoglin are elevated circulating anti-angiogenic factors in pre-eclampsia. Liu Z; Afink GB; Dijke PT Pregnancy Hypertens; 2012 Oct; 2(4):358-67. PubMed ID: 26105603 [TBL] [Abstract][Full Text] [Related]
35. Pro- and antiangiogenic markers in patients with pulmonary complications of systemic scleroderma. Głodkowska-Mrówka E; Górska E; Ciurzyński M; Stelmaszczyk-Emmel A; Bienias P; Irzyk K; Siwicka M; Lipińska A; Ciepiela O; Pruszczyk P; Demkow U Respir Physiol Neurobiol; 2015 Apr; 209():69-75. PubMed ID: 25447676 [TBL] [Abstract][Full Text] [Related]
36. Serum apelin levels: clinical association with vascular involvements in patients with systemic sclerosis. Aozasa N; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):37-42. PubMed ID: 22112232 [TBL] [Abstract][Full Text] [Related]
37. Oxidative stress-induced S100B protein from placenta and amnion affects soluble Endoglin release from endothelial cells. Tskitishvili E; Sharentuya N; Temma-Asano K; Mimura K; Kinugasa-Taniguchi Y; Kanagawa T; Fukuda H; Kimura T; Tomimatsu T; Shimoya K Mol Hum Reprod; 2010 Mar; 16(3):188-99. PubMed ID: 19939849 [TBL] [Abstract][Full Text] [Related]
38. Soluble CD163 as a Potential Biomarker in Systemic Sclerosis. Frantz C; Pezet S; Avouac J; Allanore Y Dis Markers; 2018; 2018():8509583. PubMed ID: 29805720 [TBL] [Abstract][Full Text] [Related]
39. Elevated vascular endothelial growth factor in systemic sclerosis. Choi JJ; Min DJ; Cho ML; Min SY; Kim SJ; Lee SS; Park KS; Seo YI; Kim WU; Park SH; Cho CS J Rheumatol; 2003 Jul; 30(7):1529-33. PubMed ID: 12858453 [TBL] [Abstract][Full Text] [Related]